Increased infiltration and activation of CD8+ T cells in STAT3 inhibited tumours, in comparison to genetic inhibition of pSTAT3+myMAFs alone, suggests an additive effect, likely mediated by the additional suppression of cancer-cell derived Osteopontin. The gene discussed is CD8A; the disease is cancer.